Your browser doesn't support javascript.
loading
Combining anti-IL-7Rα antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.
Vazquez-Mateo, Cristina; Collins, Justin; Goldberg, Sarah J; Lawson, Maxx; Hernandez-Escalante, Jaileene; Dooms, Hans.
Afiliação
  • Vazquez-Mateo C; Arthritis Center, Rheumatology Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Collins J; Arthritis Center, Rheumatology Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Goldberg SJ; Arthritis Center, Rheumatology Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Lawson M; Arthritis Center, Rheumatology Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Hernandez-Escalante J; Arthritis Center, Rheumatology Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Dooms H; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
PLoS One ; 14(3): e0214379, 2019.
Article em En | MEDLINE | ID: mdl-30908554
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoantígenos / Citocinas / Diabetes Mellitus Tipo 1 / Subunidade alfa de Receptor de Interleucina-7 / Anticorpos Monoclonais Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoantígenos / Citocinas / Diabetes Mellitus Tipo 1 / Subunidade alfa de Receptor de Interleucina-7 / Anticorpos Monoclonais Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article